Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Pavel L. Anufriev"'
Publikováno v:
Анналы клинической и экспериментальной неврологии, Vol 16, Iss 2, Pp 78-88 (2022)
This review contains up-to-date information on the fundamentals and clinical aspects of white matter disease in chronic progressive cerebrovascular disease with cognitive impairment, the leading risk factors for which are hypertension and cerebral at
Externí odkaz:
https://doaj.org/article/76e3ef5b1526419ca573c1a561d4c639
Publikováno v:
Анналы клинической и экспериментальной неврологии, Vol 14, Iss 2, Pp 50-61 (2020)
Introduction. Hepatolenticular degeneration (HLD), or Wilson disease, is one of the severe progressive hereditary disorders of the nervous system. A number of questions regarding its pathogenesis and pathology are the subject of in-depth research.
Externí odkaz:
https://doaj.org/article/225c55e6b26b49bcabc83eabc06a2318
Publikováno v:
Анналы клинической и экспериментальной неврологии, Vol 12, Iss 4, Pp 16-22 (2018)
Introduction. Pathomorphological studies allow verifying clinical data concerning diagnostic features and predictors of ischemic strokes. Small number and inconsistency of such works have determined the objective of this study: to refine morphologica
Externí odkaz:
https://doaj.org/article/ecaccb9f3dfb47a7ab795a84b1a4ce8e
Autor:
Marine M. Tanashyan, Renat E. Ablyakimov, Tat'yana S. Gulevskaya, Pavel L. Anufriev, Anna N. Evdokimenko
Publikováno v:
Анналы клинической и экспериментальной неврологии, Vol 12, Iss 1, Pp 12-18 (2018)
Introduction. An important objective of neurology is to clarify the pathogenesis of ischemic strokes and the diagnostic distinction of their pathogenetic subtypes that determines the possibility of targeted treatment and adequate prevention of stroke
Externí odkaz:
https://doaj.org/article/dfe7639be2bc4e7182f0d067dacc7953
Publikováno v:
Анналы клинической и экспериментальной неврологии, Vol 10, Iss 4, Pp 5-10 (2017)
Introduction.An important objective of vascular neurology is toimprove understanding of the pathogenetic subtypes of ischemicstroke and their diagnostic criteria, making it possible to performtargeted treatment and adequate prevention of cerebral cir
Externí odkaz:
https://doaj.org/article/4a0704ebe2d64a849a578f8c5c0283eb
Publikováno v:
Arkhiv patologii. 83:45
Hypertension is the main cause and the most important risk factor for both acute cerebrovascular accident and chronic progressive cerebrovascular insufficiency that is accompanied by severe neurological and mental disorders even to the extent of deve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d84da22c7bd71c808d80ff51d775140
https://doi.org/10.17116/patol20218306145
https://doi.org/10.17116/patol20218306145
Publikováno v:
Arkhiv patologii. 80:3
to obtain more specific information on the morphology and pathogenesis of cerebral infarctions occurring in vertebrobasilar artery (VBA) atherosclerosis.Macro- and microscopic investigations of the brain, its arterial system, and heart were conducted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5826802354beb68884d37116178b78ae
https://doi.org/10.17116/patol20188013-10
https://doi.org/10.17116/patol20188013-10
Autor:
Tat'yana S. Gulevskaya, Marine M. Tanashyan, Pavel L. Anufriev, K N Kulichenkova, A N Evdokimenko
Publikováno v:
Arkhiv patologii. 80:24
to identify the relationship between the magnitude of neovascularization of an atherosclerotic plaque and its other processes, such as atheromatosis, macrophage responses, hemorrhages, and calcification.48 carotid atherosclerotic plaques all their wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f603255cddf43759cf41cf97f45c4b8e
https://doi.org/10.17116/patol201880224-29
https://doi.org/10.17116/patol201880224-29
Publikováno v:
Atherosclerosis. 263:e126
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8616c1a3ba679a462dfa93e8f1c761ec
https://doi.org/10.1016/j.atherosclerosis.2017.06.404
https://doi.org/10.1016/j.atherosclerosis.2017.06.404